Dr. Jason A. Roostaeian, MD

Dr. Roostaeian practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Roostaeian's NPI, 1346491552, was assigned on October 7, 2008. Dr. Roostaeian graduated from David Geffen School of Medicine at UCLA in 2006. Dr. Roostaeian's California license number on file is A103442.

Dr. Roostaeian's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Roostaeian's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Roostaeian is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Dr. Roostaeian to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roostaeian practices, 2 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Roostaeian's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Roostaeian is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Roostaeian's licenses on file in 2 states: California and Texas.

Dmand AI lists breast reconstruction and breast surgery among the conditions Dr. Roostaeian treats.

CMS data shows 188 Medicare services from Dr. Roostaeian across 9 procedure codes in 2024, for 95 Medicare patients. Medicare paid $52,340 for them.

CMS counts 95 Medicare patients who saw Dr. Roostaeian in 2024. The largest group is 65 to 74, with 39 patients. 73% of them have high cholesterol, and 63% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Roostaeian's median patient age at 49, with 61% women.

In 2024, Dr. Roostaeian wrote 16 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $102 in total drug cost. In 2021, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Roostaeian for performance year 2024, reported as part of a group. Dr. Roostaeian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Roostaeian as offering telehealth. CMS counts 62 procedures of melanoma (skin cancer) excision by Dr. Roostaeian, more than 89% of the clinicians it reports for that procedure.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Roostaeian, published from 2010 to 2025. Dr. Roostaeian's most frequent co-authors are Fernando A. Herrera, MD, Andrew Louis Da Lio, MD and Jaco Hagop Festekjian, MD.

CMS Open Payments shows 305 general payments to Dr. Roostaeian from 36 drug and device companies from 2016 to 2025. Acquisitions make up the largest share, 65% of the total. Surgical Innovation Associates, Inc. paid the most, $104,375.

Dmand AI lists 2 awards for Dr. Roostaeian, most recently Alpha Omega Alpha Medical Honor Society in 2006.

Dr. Roostaeian graduated from David Geffen School of Medicine at UCLA in 2006. Dr. Roostaeian is a member of ASAPS and ASPS.

Dr. Roostaeian is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.